Nifty
Sensex
:
:
24363.30
79857.79
-232.85 (-0.95%)
-765.47 (-0.95%)

Hospital & Healthcare Services

Rating :
64/99

BSE: 543220 | NSE: MAXHEALTH

1245.30
08-Aug-2025
  • Open
  • High
  • Low
  • Previous Close
  •  1265
  •  1271.4
  •  1242.3
  •  1265.90
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  548971
  •  687037196
  •  1314.3
  •  836.6

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,20,983.67
  • 114.51
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,22,790.61
  • 0.12%
  • 13.30

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 23.74%
  • 0.15%
  • 3.43%
  • FII
  • DII
  • Others
  • 54.76%
  • 16.21%
  • 1.71%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 17.14
  • 22.89
  • 15.49

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 31.88
  • 36.84
  • 8.44

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -0.84

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 75.20
  • 71.13

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 7.60
  • 9.05

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 45.12
  • 46.39

Earnings Forecasts:

(Updated: 06-06-2025)
Description
2024
2025
2026
2027
Adj EPS
10.89
11.07
19
23.77
P/E Ratio
116.24
114.35
66.63
53.26
Revenue
5309
7028
10494
12633
EBITDA
1492
1849
2880
3540
Net Income
1058
1076
1805
2263
ROA
9.6
7.9
11.6
13.5
P/B Ratio
16.02
13.12
10.21
8.68
ROE
13.37
12.1
16.39
17.22
FCFF
317
493
328
1033
FCFF Yield
0.28
0.43
0.29
0.91
Net Debt
200
2328
1235
337
BVPS
79.03
96.5
124
145.92

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Net Sales
1,909.74
1,422.90
34.21%
1,868.31
1,334.97
39.95%
1,707.46
1,363.16
25.26%
1,542.95
1,284.99
20.07%
Expenses
1,398.12
1,041.37
34.26%
1,369.18
949.11
44.26%
1,256.92
975.81
28.81%
1,155.54
947.61
21.94%
EBITDA
511.62
381.53
34.10%
499.13
385.86
29.36%
450.54
387.35
16.31%
387.41
337.38
14.83%
EBIDTM
26.79%
26.81%
26.72%
28.90%
26.39%
28.42%
25.11%
26.26%
Other Income
46.92
45.25
3.69%
33.30
46.02
-27.64%
40.84
45.48
-10.20%
34.68
41.32
-16.07%
Interest
55.21
20.73
166.33%
52.39
11.24
366.10%
33.54
8.53
293.20%
23.88
19.39
23.16%
Depreciation
100.83
70.32
43.39%
97.54
60.96
60.01%
84.15
57.88
45.39%
76.90
55.82
37.76%
PBT
402.50
335.73
19.89%
308.87
359.68
-14.13%
373.69
366.42
1.98%
321.31
303.49
5.87%
Tax
83.50
84.19
-0.82%
70.07
70.34
-0.38%
91.88
89.74
2.38%
85.04
63.41
34.11%
PAT
319.00
251.54
26.82%
238.80
289.34
-17.47%
281.81
276.68
1.85%
236.27
240.08
-1.59%
PATM
16.70%
17.68%
12.78%
21.67%
16.50%
20.30%
15.31%
18.68%
EPS
3.28
2.59
26.64%
2.46
2.98
-17.45%
2.90
2.85
1.75%
2.43
2.47
-1.62%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 16
Mar 15
Mar 14
Net Sales
-
7,028.46
5,406.02
4,562.60
3,936.55
2,507.97
1,059.03
1,691.02
1,445.40
1,133.61
944.46
Net Sales Growth
-
30.01%
18.49%
15.90%
56.96%
136.82%
-37.37%
16.99%
27.50%
20.03%
 
Cost Of Goods Sold
-
1,477.05
1,118.52
922.01
922.90
594.41
217.31
364.46
398.63
345.95
328.00
Gross Profit
-
5,551.41
4,287.50
3,640.59
3,013.65
1,913.56
841.72
1,326.56
1,046.77
787.66
616.46
GP Margin
-
78.98%
79.31%
79.79%
76.56%
76.30%
79.48%
78.45%
72.42%
69.48%
65.27%
Total Expenditure
-
5,188.03
3,924.88
3,335.14
2,998.14
2,124.34
965.45
1,545.51
1,329.79
1,058.39
914.52
Power & Fuel Cost
-
115.03
77.54
69.04
62.67
51.37
22.72
46.06
40.73
32.60
29.63
% Of Sales
-
1.64%
1.43%
1.51%
1.59%
2.05%
2.15%
2.72%
2.82%
2.88%
3.14%
Employee Cost
-
1,174.01
934.40
809.35
759.92
588.78
230.13
440.55
297.48
232.09
188.81
% Of Sales
-
16.70%
17.28%
17.74%
19.30%
23.48%
21.73%
26.05%
20.58%
20.47%
19.99%
Manufacturing Exp.
-
1,800.27
1,348.42
1,195.50
995.21
670.35
336.05
112.01
16.97
293.99
244.08
% Of Sales
-
25.61%
24.94%
26.20%
25.28%
26.73%
31.73%
6.62%
1.17%
25.93%
25.84%
General & Admin Exp.
-
507.53
382.92
303.70
226.23
165.14
129.84
563.52
476.29
142.24
114.53
% Of Sales
-
7.22%
7.08%
6.66%
5.75%
6.58%
12.26%
33.32%
32.95%
12.55%
12.13%
Selling & Distn. Exp.
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
28.30
0.00
0.00
% Of Sales
-
0%
0%
0%
0%
0%
0%
0%
1.96%
0%
0%
Miscellaneous Exp.
-
114.14
63.08
35.54
31.21
54.29
29.40
18.91
99.69
11.52
0.00
% Of Sales
-
1.62%
1.17%
0.78%
0.79%
2.16%
2.78%
1.12%
6.90%
1.02%
1.00%
EBITDA
-
1,840.43
1,481.14
1,227.46
938.41
383.63
93.58
145.51
115.61
75.22
29.94
EBITDA Margin
-
26.19%
27.40%
26.90%
23.84%
15.30%
8.84%
8.60%
8.00%
6.64%
3.17%
Other Income
-
164.01
189.05
152.31
131.51
134.97
48.08
66.72
29.78
27.27
23.48
Interest
-
165.02
59.89
83.86
100.87
179.46
83.24
101.27
73.06
61.16
62.25
Depreciation
-
359.42
244.98
232.19
221.12
174.09
45.64
102.64
86.62
78.38
55.46
PBT
-
1,480.00
1,365.32
1,063.72
747.93
165.05
12.78
8.32
-14.29
-37.05
-64.29
Tax
-
330.49
307.68
-39.79
133.85
45.85
-0.13
8.51
-0.02
0.00
0.36
Tax Rate
-
23.50%
22.54%
-3.74%
18.11%
-66.79%
-1.02%
102.28%
0.14%
0.00%
-0.56%
PAT
-
1,075.88
1,057.64
1,103.51
605.05
-114.50
12.91
-3.01
-13.77
-37.05
-64.65
PAT before Minority Interest
-
1,075.88
1,057.64
1,103.51
605.05
-114.50
12.91
-0.19
-14.27
-37.05
-64.65
Minority Interest
-
0.00
0.00
0.00
0.00
0.00
0.00
-2.82
0.50
0.00
0.00
PAT Margin
-
15.31%
19.56%
24.19%
15.37%
-4.57%
1.22%
-0.18%
-0.95%
-3.27%
-6.85%
PAT Growth
-
1.72%
-4.16%
82.38%
-
-
-
-
-
-
 
EPS
-
11.07
10.88
11.35
6.22
-1.18
0.13
-0.03
-0.14
-0.38
-0.67

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Shareholder's Funds
9,380.87
8,408.14
7,409.59
6,282.47
5,638.68
2,553.15
963.19
Share Capital
972.14
971.91
970.92
969.61
965.95
537.24
537.24
Total Reserves
8,289.06
7,368.75
6,397.04
5,290.74
4,646.22
2,015.91
425.95
Non-Current Liabilities
3,991.80
2,343.09
1,646.69
2,149.39
2,127.85
410.56
1,251.32
Secured Loans
2,270.06
1,060.33
496.08
628.91
842.32
105.73
889.10
Unsecured Loans
0.00
0.50
0.50
0.50
0.50
0.50
0.96
Long Term Provisions
98.07
75.47
60.48
59.79
60.19
40.66
18.02
Current Liabilities
1,813.77
1,248.71
1,045.57
757.27
776.93
1,009.95
1,140.03
Trade Payables
807.92
633.01
543.46
444.11
435.69
179.63
291.59
Other Current Liabilities
863.43
493.26
408.16
196.95
237.52
95.26
752.87
Short Term Borrowings
63.59
61.29
45.58
74.53
54.25
727.37
77.61
Short Term Provisions
78.83
61.15
48.37
41.68
49.47
7.69
17.96
Total Liabilities
15,186.44
11,999.94
10,101.85
9,189.13
8,543.46
3,973.66
3,354.54
Net Block
11,496.93
8,720.66
7,038.70
7,017.58
6,536.38
850.95
2,192.37
Gross Block
13,337.72
9,902.43
7,958.37
7,759.60
7,099.22
1,252.16
2,557.37
Accumulated Depreciation
1,840.79
1,181.77
919.67
742.02
562.84
401.21
365.00
Non Current Assets
13,593.87
10,293.76
8,158.78
8,188.84
7,418.99
1,058.27
2,907.24
Capital Work in Progress
900.72
553.04
252.43
151.12
26.93
27.55
87.02
Non Current Investment
2.89
2.12
0.51
0.51
0.51
0.00
0.51
Long Term Loans & Adv.
951.31
727.51
673.93
757.17
679.63
70.06
535.51
Other Non Current Assets
237.36
227.40
193.21
262.46
175.54
109.71
91.83
Current Assets
1,592.57
1,706.18
1,943.07
1,000.29
1,124.47
2,915.39
447.30
Current Investments
0.00
0.00
0.00
0.00
0.00
2,182.06
0.00
Inventories
106.21
79.84
76.23
61.36
53.80
26.80
26.01
Sundry Debtors
687.31
462.69
336.12
385.36
365.89
96.09
362.61
Cash & Bank
681.89
1,099.27
1,468.07
499.31
652.92
119.57
11.64
Other Current Assets
117.16
23.46
14.06
23.99
51.86
490.87
47.04
Short Term Loans & Adv.
75.91
40.92
48.59
30.27
37.39
478.76
36.06
Net Current Assets
-221.20
457.47
897.50
243.02
347.54
1,905.44
-692.73
Total Assets
15,186.44
11,999.94
10,101.85
9,189.13
8,543.46
3,973.66
3,354.54

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Cash From Operating Activity
1,459.31
1,121.67
1,284.13
740.52
117.86
77.09
88.95
PBT
1,406.37
1,365.32
1,063.72
738.90
-68.65
12.78
8.32
Adjustment
498.29
184.85
225.84
241.22
504.74
109.44
156.89
Changes in Working Capital
-124.41
-159.22
155.69
-130.54
-376.25
-38.84
-48.13
Cash after chg. in Working capital
1,780.25
1,390.95
1,445.25
849.58
59.84
83.38
117.08
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-320.94
-269.28
-161.12
-109.06
58.02
-6.29
-28.13
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-1,631.74
-1,285.45
-102.32
-763.80
-73.00
-2,640.70
-16.53
Net Fixed Assets
-307.51
-450.46
-140.69
-1,687.37
-2,982.65
557.88
Net Investments
-698.35
-440.62
-27.73
932.29
91.94
-1,701.27
Others
-625.88
-394.37
66.10
-8.72
2,817.71
-1,497.31
Cash from Financing Activity
-163.80
-263.74
-288.56
-294.17
191.33
2,353.12
-73.95
Net Cash Inflow / Outflow
-336.23
-427.52
893.25
-317.45
236.19
-210.49
-1.53
Opening Cash & Equivalents
979.84
1,374.33
480.97
626.59
111.01
321.50
9.13
Closing Cash & Equivalent
661.24
979.71
1,374.33
309.14
626.59
111.01
7.60

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Book Value (Rs.)
95.27
85.82
75.89
64.57
58.10
47.52
17.93
ROA
7.91%
9.57%
11.44%
6.82%
-1.83%
0.35%
-0.01%
ROE
12.22%
13.47%
16.19%
10.19%
-2.80%
0.73%
-0.02%
ROCE
14.67%
16.26%
15.32%
12.38%
2.22%
3.57%
5.32%
Fixed Asset Turnover
0.60
0.61
0.58
0.53
0.60
0.56
0.67
Receivable days
29.86
26.97
28.86
34.83
33.62
79.05
66.97
Inventory Days
4.83
5.27
5.50
5.34
5.87
9.10
5.86
Payable days
178.04
191.96
195.48
173.98
188.92
99.45
94.83
Cash Conversion Cycle
-143.35
-159.72
-161.11
-133.81
-149.44
-11.30
-22.01
Total Debt/Equity
0.27
0.14
0.08
0.12
0.16
0.33
1.05
Interest Cover
9.52
23.80
13.68
8.33
0.62
1.15
1.08

News Update:


  • Max Healthcare Institute transfers equity shares of Sandhya Hydro Power Projects Balargha
    14th Jul 2025, 11:53 AM

    The company has transferred 12,84,396 equity shares of Sandhya Hydro Power Projects Balargha

    Read More
  • Max Healthcare Institute reports 27% jump in Q4 consolidated net profit
    21st May 2025, 15:12 PM

    The total consolidated income of the company increased by 33.38% at Rs 1,956.66 crore for Q4FY25

    Read More
  • Max Healthcare Institute’s arm executes sale deed for acquisition of land and building in UP
    17th May 2025, 11:12 AM

    This strategic acquisition paves the way for the addition of around 140 beds at MSSH, Vaishali over period of next 30 months

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.